Dr. Chelsee Jensen, a Pharmaceutical Formulary Manager, and Dr. Eric Tichy, Division Chair for Supply Chain Management, both at Mayo Clinic in Rochester, MN, review their article appearing in the June 2022 issue of Mayo Clinic Proceedings, where they describe the process for implementing a Quality Improvement project using 5 oncology medications as models at Mayo Clinic to foster the use of biosimilars. The program resulted in significant cost decreases without jeopardizing the safety and efficacy of the medications used. Dr. Tichy and Dr. Jensen offer insights for patients into what they might be experience with the use of biosimilars and they encourage clinicians to become familiar with the rules and regulations for biosimilar use to help make the cost of medicines more sustainable in the future. Available at: [ Ссылка ]

свернуть